Tuesday, June 30, 2015

Pharmalink AB acquires anti-inflammatory drug candidate from Synartro AB

›
Pharmalink AB, a specialty pharma company, announces that it has acquired a novel product candidate in development for treating inflammati...
Monday, June 29, 2015

Novel molecule inhibits cancer-causing transcription factors

›
A novel molecule designed by scientists at the University of Massachusetts Medical School and the University of Virginia inhibits ...
Friday, June 26, 2015

Pharmalink AB acquires anti-inflammatory drug candidate from Synartro AB

›
Pharmalink AB, a specialty pharma company, announces that it has acquired a novel product candidate in development for treating inflammati...
Wednesday, June 24, 2015

GFT505 demonstrates dose-dependent efficacy on primary endpoint in phase 2 NASH trial

›
GENFIT (Euronext: GNFT; ISIN: FR0004163111), today announces topline results of the phase 2 GOLDEN-505 trial in NASH. Due to...
Tuesday, June 23, 2015

Anti-diabetic medication activates brain sensors, promotes weight gain

›
Medication used to treat patients with type II diabetes activates sensors on brain cells that increase hunger, causing people taking this ...
Monday, June 22, 2015

Promising drug a 'new paradigm' for treating leukemia

›
Researchers at the University of Virginia School of Medicine have developed a compound that delays leukemia in mice and effectively ki...
Friday, June 19, 2015

Common bacteria on verge of becoming antibiotic-resistant superbugs

›
Anti biotic resistance is poised to spread globally among bacteria frequently implicated in respiratory and urinary infections in hosp...
Thursday, June 18, 2015

New drug fails to prevent irreversible injury to the heart after angioplasty

›
Patients who received the new drug Bendavia before undergoing angioplasty or receiving a stent to clear blocked arteries after a hea...

Sildenafil drug may effectively relieve nerve damage in men with long-term diabetes

›
New animal studies at Henry Ford Hospital found that sildenafil, a drug commonly used to treat erectile dysfunction, may be effective in r...
Wednesday, June 17, 2015

FDA approves CHOLBAM (cholic acid) for treatment of bile acid synthesis disorders

›
          Asklepion Pharmaceuticals, LLC. today announced that the U.S. Food and Drug Administration (FDA) approved CHOLBAM™ (cholic a...
Tuesday, June 16, 2015

CASI initiates ENMD-2076 Phase 2 trial in Chinese patients with triple-negative breast cancer

›
         CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to the acquisition, development and commer...
Monday, June 15, 2015

Existing drugs could help prevent deadly familial stomach and lobular breast cancers

›
Deadly familial stomach and lobular breast cancers could be successfully treated at their earliest stages, or even prevented, by existing ...
Friday, June 12, 2015

Saccharin could potentially lead to development of drugs for difficult-to-treat cancers

›
Saccharin, the artificial sweetener that is the main ingredient in Sweet 'N Low®, Sweet Twin® and Necta®, could do far more than...
Thursday, June 11, 2015

Isis Pharmaceuticals announces positive results from ISIS-ANGPTL3Rx Phase 1 study

›
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today positive results from a Phase 1 study with ISIS-ANGPTL3 Rx . In this study, heal...
Wednesday, June 10, 2015

Glyxambi for Type 2 diabetes treatment now available by prescription across the U.S.

›
In continuation of my update on  empagliflozin / linagliptin                              Glyxambi® (empagliflozin/linagliptin) ta...